"Generic medicines are a vital part of ensuring that health care will remain affordable and accessible to all Americans," said GPhA President and CEO Kathleen Jaeger, speaking at the Association's Annual Meeting in Boca Raton, Florida.
"Given the enormous pressure to hold down costs in the U.S. health care system, it's clear that the generic industry will continue to play a key role in leading America into a healthy future. "
Speakers will include:
Alex Azar II, Deputy Secretary, U.S. Department of Health and Human Services
Tommy Erdei, Director of Healthcare, ABN AMRO
Hon. Richard L. Armitage, Former U.S. Deputy Secretary of State
U.S. Representative Henry A. Waxman, 30th District, California
Robert Reich, Former U.S. Secretary of Labor
Governor Joseph Manchin III, West Virginia
Scott Gottlieb, M.D., Deputy Commissioner for Medical & Scientific Affairs, Food and Drug Administration
Graham Lewis, V.P. Strategic & Global Solutions, Europe and World-Wide, IMS Health
Douglas Long, V.P., Industrial Relations, IMS Health
Douglas Holtz Eakin, Former Director, Congressional Budget Office
Gregg Gilbert, Vice President Research, Health Care, Merrill Lynch
Gary Buehler, R.Ph., Director, Office of Generic Drugs, Food and Drug Administration
Mac Crawford, Chairman and CEO, Caremark Rx, Inc.
Generics represent 53% of the total prescriptions dispensed in the United States, but less than 12% of all dollars spent on prescription drugs.
Well, money has to be saved somewhere to pay for Avastin!
http://www.gphaonline.org
No comments:
Post a Comment